Fund Portfolios

Latest stock portfolios of the world's best investors and hedge funds

Stocks ranked by hedge fund and large institutional investor activity

Large Buys & Sells

Recent large buys and sells by hedge funds and large institutional investors

Stocks ranked by analyst price target upside potential

Latest Price Targets

Latest analyst price targets & ratings by research analysts

Research analysts, their latest ratings and performance metrics

Research analyst firms, their latest ratings and performance metrics

Fund Manager Index

Stock index based on fund manager activity updated each quarter

Sign in Sign up

Neurocrine Biosciences

NBIX

Market cap $13.9B

Overview Fund Activity

140.40 USD

+4.29

3.15%

At close Updated Sep 4, 4:00 PM EDT

Pre-market

After hours

140.40

0.00

0%

1 day

3.15%

5 days

1.67%

1 month

9.65%

3 months

12.75%

6 months

24.13%

Year to date

1.84%

1 year

14.57%

5 years

27.57%

10 years

189.19%

Fund managers haven't disclosed holdings of this stock as yet.

Product

Portfolios Fund Trends Large Buys & Sells Analyst Upside Analyst Price Targets Analysts Analyst Firms Stocks ETFs Sectors Industries Rankings

Resources

Plans Learn API Access

Policies

Terms & Conditions Privacy Policy Disclaimer Climate Commitment

Connect

Contact Us About X (Twitter) LinkedIn

© 2025 Wall St. Rank

Sign up Sign in

Fund Portfolios Latest stock portfolios of the world's best investors and hedge funds Fund Trends Stocks ranked by hedge fund and large institutional investor activity Large Buys & Sells Recent large buys and sells by hedge funds and large institutional investors

Analyst Upside Stocks ranked by analyst price target upside potential Latest Price Targets Latest analyst price targets & ratings by research analysts Analysts Research analysts, their latest ratings and performance metrics Analyst Firms Research analyst firms, their latest ratings and performance metrics

Fund Manager Index Stock index based on fund manager activity updated each quarter

Theme